Cannabis Bioscience International Holdings (CBIH) Change in Accured Expenses (2022 - 2025)
Historic Change in Accured Expenses for Cannabis Bioscience International Holdings (CBIH) over the last 5 years, with Q3 2025 value amounting to $952.0.
- Cannabis Bioscience International Holdings' Change in Accured Expenses rose 10159.23% to $952.0 in Q3 2025 from the same period last year, while for Aug 2025 it was -$4777.0, marking a year-over-year increase of 8580.43%. This contributed to the annual value of -$65515.0 for FY2025, which is 17726.83% down from last year.
- According to the latest figures from Q3 2025, Cannabis Bioscience International Holdings' Change in Accured Expenses is $952.0, which was up 10159.23% from -$23893.0 recorded in Q2 2025.
- In the past 5 years, Cannabis Bioscience International Holdings' Change in Accured Expenses registered a high of $58654.0 during Q3 2023, and its lowest value of -$661399.0 during Q4 2022.
- For the 4-year period, Cannabis Bioscience International Holdings' Change in Accured Expenses averaged around -$49477.5, with its median value being $11987.5 (2023).
- Per our database at Business Quant, Cannabis Bioscience International Holdings' Change in Accured Expenses soared by 10658.69% in 2023 and then tumbled by 35159.3% in 2024.
- Cannabis Bioscience International Holdings' Change in Accured Expenses (Quarter) stood at -$661399.0 in 2022, then soared by 106.59% to $43566.0 in 2023, then plummeted by 31.56% to $29817.0 in 2024, then crashed by 96.81% to $952.0 in 2025.
- Its Change in Accured Expenses stands at $952.0 for Q3 2025, versus -$23893.0 for Q2 2025 and -$11653.0 for Q1 2025.